Literature DB >> 11131310

Voiding dysfunction in the orthotopic neobladder.

W D Steers1.   

Abstract

The orthotopic neobladder has become the preferred method of handling the urinary tract after removal of the bladder in men and women. However, an improved quality of life compared to urinary diversion fails to be realized when voiding dysfunction arises. These difficulties with urination range from retention to incontinence. Voiding dysfunction following neobladder construction that persists beyond 6-12 months warrants fluoro-urodynamic evaluation to determine the cause and plan therapy. Although colonic, ileocolonic, gastric, and ileal neobladders have all been deemed acceptable, the S or W-configured, spheroidal shaped neobladders created from ileum are the most popular. Voiding pressures and micturition patterns depend on the type, length, and configuration of bowel segment harvested. These variables also determine the risk of voiding dysfunction, along with the choice of surgical technique, and the age and sex of the patient. Urinary retention is more common in women, especially after urethral nerve sparing. Obstruction is often due to inferior displacement of the bladder neck, which can angulate the urethra. Daytime stress incontinence arises from reduced urethral outlet resistance accentuated by low neobladder capacity, reduced compliance, or elevated neobladder pressures. Night-time incontinence develops as a consequence of absent sensation that permits excessive nocturnal volumes to overcome the impaired continence mechanisms of the bladder outlet. This situation is exacerbated by the loss of physiological storage reflexes. Therapy for retention rests primarily with intermittent self-catheterization. Stress urinary incontinence can be treated with periurethral bulking agents or an artificial urethral sphincter. Nocturnal enuresis is often effectively managed by the use of an alarm clock to awaken the patient several times per night. Knowledge of the pathogenesis and identification of risk factors implies that prevention through proper design of the neobladder, meticulous surgical technique, and patient selection is paramount.

Entities:  

Mesh:

Year:  2000        PMID: 11131310     DOI: 10.1007/s003450000146

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  35 in total

Review 1.  Surgical complications of urinary diversion.

Authors:  Scott B Farnham; Michael S Cookson
Journal:  World J Urol       Date:  2004-08-13       Impact factor: 4.226

Review 2.  Complications associated with urinary diversion.

Authors:  Richard E Hautmann; Stefan H Hautmann; Oliver Hautmann
Journal:  Nat Rev Urol       Date:  2011-11-01       Impact factor: 14.432

3.  Surgery: preserving continence in muscle-invasive bladder cancer.

Authors:  Anthony Costello; Rajiv Goel
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

4.  Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort.

Authors:  Florian Roghmann; Andreas Becker; Quoc-Dien Trinh; Orchidee Djahangirian; Orchidee Djahagirian; Zhe Tian; Malek Meskawi; Shahrokh F Shariat; Markus Graefen; Pierre Karakiewicz; Joachim Noldus; Maxine Sun
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

5.  Is sparing the prostate still considered radical cystectomy? The case against prostate-sparing cystectomy for bladder cancer.

Authors:  Ahmed Kotb; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

6.  Voiding symptoms and urodynamic findings in patients with modified ileal neobladde.

Authors:  Attila Keszthelyi; Attila Majoros; Péter Nyirády; Peter Mayer; Dietmar Bach; Imre Romics
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience.

Authors:  Xin Gou; Ming Wang; Wei-yang He; Cao-Dong Liu; Yuan-zhong Deng; Ke Ren; Yong Chen
Journal:  Int Urol Nephrol       Date:  2012-01-17       Impact factor: 2.370

8.  Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action.

Authors:  Adrian S Fairey; Ryan Mclarty
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

Review 9.  Management of Voiding Dysfunction After Female Neobladder Creation.

Authors:  Nathan Y Hoy; Joshua A Cohn; Casey G Kowalik; Melissa R Kaufman; W Stuart Reynolds; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

10.  V-Loc urethro-intestinal anastomosis during robotic cystectomy with orthotopic urinary diversion.

Authors:  Khanh N Pham; Bryan S Sack; R Corey O'Connor; Michael L Guralnick; Peter Langenstroer; William A See; Kenneth Jacobsohn
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.